{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:47:34Z","timestamp":1751867254149,"version":"3.32.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jsps.2024.102204","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T21:53:49Z","timestamp":1731102829000},"page":"102204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective"],"prefix":"10.1007","volume":"32","author":[{"given":"A.","family":"Alshahrani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0571-7230","authenticated-orcid":false,"given":"S.","family":"Al-Aqeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.T.","family":"Alhawwashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Al-Nasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zaitoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2024.102204_b0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11136-024-03645-9","article-title":"Estimation of health utility values for alopecia areata","author":"Aggio","year":"2024","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jsps.2024.102204_b0010","doi-asserted-by":"crossref","DOI":"10.1007\/s11136-021-03010-0","article-title":"Patient-reported outcome measures in Arabic-speaking populations: A systematic review","author":"Alaqeel","year":"2022","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.jsps.2024.102204_b0015","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7194270","article-title":"Prevalence and clinical characteristics of Alopecia Areata at a Tertiary Care Center in Saudi Arabia","volume":"2020","author":"Alshahrani","year":"2020","journal-title":"Dermatol. Res. Pract."},{"key":"10.1016\/j.jsps.2024.102204_b0020","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s13555-023-00963-7","article-title":"Treatment patterns and unmet needs in the management of Alopecia Areata: Results of a physician\u2019s survey in the Middle East","volume":"13","author":"Ammoury","year":"2023","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"10.1016\/j.jsps.2024.102204_b0025","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/13696998.2019.1632203","article-title":"A proposal for value informed, affordable (\u201cvia\u201d) prices for innovative medicines","volume":"11","author":"Annemans","year":"2019","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.jsps.2024.102204_b0030","doi-asserted-by":"crossref","DOI":"10.1007\/s40258-021-00652-6","article-title":"Systematic literature review of guidelines on budget impact analysis for health technology assessment","author":"Chugh","year":"2021","journal-title":"Appl. Health Econ. Health Policy"},{"key":"10.1016\/j.jsps.2024.102204_b0035","doi-asserted-by":"crossref","DOI":"10.1007\/s13555-023-00991-3","article-title":"Diagnosis and management of Alopecia Areata: A Saudi expert consensus statement (2023)","author":"Fatani","year":"2023","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"10.1016\/j.jsps.2024.102204_b0040","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1016\/j.jval.2022.04.570","article-title":"Budget impact of baricitinib for patients with severe Alopecia Areata","volume":"25","author":"Fenske","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.jsps.2024.102204_b0045","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-023-01873-w","article-title":"Baricitinib for the treatment of Alopecia Areata","author":"Freitas","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jsps.2024.102204_b0050","doi-asserted-by":"crossref","DOI":"10.1007\/s10198-017-0933-3","article-title":"The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: Relationship to cost-effectiveness analysis and methodological challenges","author":"Ghabri","year":"2018","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.jsps.2024.102204_b0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2021.08.043","article-title":"Development of the alopecia areata scale for clinical use: Results of an academic\u2013industry collaborative effort","volume":"86","author":"King","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jsps.2024.102204_b0060","doi-asserted-by":"crossref","DOI":"10.1007\/s13555-022-00711-3","article-title":"Defining severity in Alopecia Areata: Current perspectives and a multidimensional framework","author":"King","year":"2022","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"10.1016\/j.jsps.2024.102204_b0065","doi-asserted-by":"crossref","first-page":"e2320351","DOI":"10.1001\/jamanetworkopen.2023.20351","article-title":"Janus kinase inhibitors for Alopecia Areata: A systematic review and meta-analysis","volume":"6","author":"Liu","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jsps.2024.102204_b0070","doi-asserted-by":"crossref","unstructured":"Mateos-Haro, M., N.-C.M., S.V.G., C.-P.A., G.G.A., F.-G.S., O.-Q.D., U.R.M.G., S.-C.D., B.-D.T., G.L., T.J., V.-G.S., & Z.J., 2023. Treatments for alopecia areata: a network meta-analysis. Cochrane Database Syst Rev.","DOI":"10.1002\/14651858.CD013719.pub2"},{"key":"10.1016\/j.jsps.2024.102204_b0075","doi-asserted-by":"crossref","unstructured":"Mostaghimi, A., Gandhi, K., Pharm, B., Done, N., Ray, M., Gao, W., Carley, C., Wang, T., Swallow, E., Sikirica, V., 2022. All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.","DOI":"10.18553\/jmcp.2022.28.4.426"},{"key":"10.1016\/j.jsps.2024.102204_b0080","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.18926","article-title":"The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity","author":"Muntyanu","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jsps.2024.102204_b0085","unstructured":"National Institute for Health and care Excellence (2023). Baricitinib for treating severe alopecia areata. Technology appraisal guidance (TA926)."},{"key":"10.1016\/j.jsps.2024.102204_b0090","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/1346-8138.16888","article-title":"Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real-world data","volume":"50","author":"Ohyama","year":"2023","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jsps.2024.102204_b0095","unstructured":"Olumiant (Baricitinib) Health care provider guide [WWW Document], 2023. https:\/\/www.sfda.gov.sa\/en\/node\/79153."},{"key":"10.1016\/j.jsps.2024.102204_b0100","doi-asserted-by":"crossref","DOI":"10.1007\/s40261-023-01260-z","article-title":"Safety of Janus kinase inhibitors in patients with Alopecia Areata: A systematic review","author":"Papierzewska","year":"2023","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jsps.2024.102204_b0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","article-title":"Budget impact analysis - Principles of good practice: Report of the ISPOR 2012 budget impact analysis good practice II task force","volume":"17","author":"Sullivan","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.jsps.2024.102204_b0110","article-title":"Epidemiology and burden of alopecia areata: A systematic review","author":"Villasante Fricke","year":"2015","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.jsps.2024.102204_b0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40273-019-00829-x","article-title":"A budget impact and cost per additional responder analysis for baricitinib for the treatment of moderate-to-severe rheumatoid arthritis in patients with an inadequate response to tumor necrosis factor inhibitors in the USA","volume":"38","author":"Wehler","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jsps.2024.102204_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1152513","article-title":"Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: A network meta-analysis","author":"Wei","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jsps.2024.102204_b0125","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-021-08883-0","article-title":"Alopecia Areata: An update on etiopathogenesis, diagnosis, and management","author":"Zhou","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jsps.2024.102204_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/ski2.301","article-title":"Establishing the financial burden of alopecia areata and its predictors","volume":"4","author":"Zucchelli","year":"2024","journal-title":"Skin Health Disease"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901642400255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S131901642400255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:26:01Z","timestamp":1736184361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S131901642400255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S131901642400255X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2024.102204","relation":{},"ISSN":["1319-0164"],"issn-type":[{"type":"print","value":"1319-0164"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2024.102204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"102204"}}